Author Question: A client is receiving treatment for angina with a vasodilator. The nurse instructs the client to ... (Read 57 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
A client is receiving treatment for angina with a vasodilator. The nurse instructs the client to notify his primary health care provider about which of the following? Select all that apply.
 
  A) Weight loss of 2 lb in a week
  B) Swelling of the extremities
  C) Episodes of dyspnea
  D) Heart rate increased by about 10 bpm
  E) Fainting

Question 2

When instructing the client on how to use the prescribed nitroglycerin ointment, the nurse would tell the client to use which of the following to determine the amount?
 
  A) A teaspoon
  B) Length of a finger
  C) Paper applicator
  D) The size of the previous dose



JYan

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Ans: B, C, E
Feedback:
The primary health care provider should be notified if the client experiences a heart rate of 20 bpm or more above the normal rate; rapid weight gain of 5 lb or more; unusual swelling of the extremities, face, or abdomen; dyspnea; angina; severe indigestion; or fainting.

Answer to Question 2

Ans: C
Feedback:
The topical ointment is supplied with a paper applicator to determine the amount of drug to be used. No other method is appropriate.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

For a complete list of videos, visit our video library